145 related articles for article (PubMed ID: 3132441)
21. Evaluation of imipenem/cilastatin for treatment of infection in an elderly population.
Smith MD; Bielawska C; Kelsey MC; Rai G; Deaney NB
J Antimicrob Chemother; 1988 Apr; 21(4):481-7. PubMed ID: 3378960
[TBL] [Abstract][Full Text] [Related]
22. Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children.
Freij BJ; Kusmiesz H; Shelton S; Nelson JD
Am J Dis Child; 1987 Mar; 141(3):335-42. PubMed ID: 3544811
[TBL] [Abstract][Full Text] [Related]
23. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.
Hashimoto S; Wolfe E; Guglielmo B; Shanks R; Sundelof J; Pittet JF; Thomas E; Wiener-Kronish J
J Antimicrob Chemother; 1996 Nov; 38(5):809-18. PubMed ID: 8961050
[TBL] [Abstract][Full Text] [Related]
24. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
25. Thienamycin: development of imipenen-cilastatin.
Kahan FM; Kropp H; Sundelof JG; Birnbaum J
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.
Somani P; Freimer EH; Gross ML; Higgins JT
Antimicrob Agents Chemother; 1988 Apr; 32(4):530-4. PubMed ID: 3377464
[TBL] [Abstract][Full Text] [Related]
27. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
28. [A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections].
Suzuki K; Takanashi K; Naide Y; Fujita T; Ogawa T; Hirabayashi S; Tamai H; Yanaoka M; Ishiguro K; Asano H
Hinyokika Kiyo; 1986 Sep; 32(9):1387-408. PubMed ID: 3101448
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa-acquired resistance to imipenem-cilastatin: commentary on clinical implications of antibiotic resistance.
Tidwell BH; Cleary JD
Pharmacotherapy; 1993; 13(2):165; discussion 166. PubMed ID: 8469624
[No Abstract] [Full Text] [Related]
30. [Imipenem/cilastatin in surgical intensive medicine].
Wenk H; Schier H; Hollandt H; Valesky A
Infection; 1986; 14 Suppl 2():S171-5. PubMed ID: 3759252
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
[TBL] [Abstract][Full Text] [Related]
32. Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction.
Wathen CG; Carbarns NJ; Jones PA; Millar A; Croughan MJ; Calder MA; Douglas NJ
J Antimicrob Chemother; 1988 Jan; 21(1):107-12. PubMed ID: 3356618
[TBL] [Abstract][Full Text] [Related]
33. Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics.
Calandra GB; Raupp W; Brown KR
Scand J Infect Dis Suppl; 1987; 52():15-9. PubMed ID: 3483286
[TBL] [Abstract][Full Text] [Related]
34. Imipenem/cilastatin for pediatric infections in hospitalized patients.
Nalin DR; Hart CB; Shih WJ; Aziz MA
Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
[TBL] [Abstract][Full Text] [Related]
35. Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin.
Verdon MS; Judson FN; Ehret JM; Root CJ; Hook EW; McCormack WM; Frances CA; Draft K; Shands JW; Handsfield HH
Antimicrob Agents Chemother; 1988 May; 32(5):773-4. PubMed ID: 3395105
[TBL] [Abstract][Full Text] [Related]
36. [New antimicrobial agent series XXV: imipenem/cilastatin sodium].
Mashimo K
Jpn J Antibiot; 1987 Oct; 40(10):1713-23. PubMed ID: 3327961
[No Abstract] [Full Text] [Related]
37. Biliary excretion of imipenem-cilastatin in hospitalized patients.
Graziani AL; Gibson GA; MacGregor RR
Antimicrob Agents Chemother; 1987 Nov; 31(11):1718-21. PubMed ID: 3435120
[TBL] [Abstract][Full Text] [Related]
38. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
Norrby SR; Eriksson M; Ottosson E
Scand J Infect Dis; 1986; 18(4):371-4. PubMed ID: 3094139
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
40. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
